Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Bellezza

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|August 5, 2004
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFederico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.
Genes|July 2, 2021
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with ImmunotherapySara Baglivo, Fortunato Bianconi, Giulio Metro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncologyVienna Ludovini, Lorenza Pistola, Vanesa Gregorc, et al.
Virchows Archiv : an International Journal of Pathology|November 19, 2018
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implicationsMartina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Frontiers in Immunology|June 16, 2020
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic ToolMartina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Genes|March 6, 2021
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer PatientsVienna Ludovini, Fortunato Bianconi, Annamaria Siggillino, et al.
The Journal of Biological Chemistry|July 4, 2020
Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brainRita Marinelli, Pierangelo Torquato, Desirée Bartolini, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2025
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosisMario Mandalà, Filippo Ugolini, Lorenzo Caldirola, et al.
Biopreservation and Biobanking|May 16, 2023
A New Medium (HistoCold) for Surgical Specimens Preserving to Improve the Preanalytic Issues in Histopathological Samples Handling: Morphologic and Antigenic AnalysisMartina Mandarano, Cristina Pelliccia, Laura Tomasello, et al.
Journal of Medicinal Chemistry|March 12, 2020
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X ReceptorDesirée Bartolini, Francesca De Franco, Pierangelo Torquato, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|August 5, 2004
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFederico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.
Genes|July 2, 2021
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with ImmunotherapySara Baglivo, Fortunato Bianconi, Giulio Metro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncologyVienna Ludovini, Lorenza Pistola, Vanesa Gregorc, et al.
Virchows Archiv : an International Journal of Pathology|November 19, 2018
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implicationsMartina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Frontiers in Immunology|June 16, 2020
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic ToolMartina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Genes|March 6, 2021
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer PatientsVienna Ludovini, Fortunato Bianconi, Annamaria Siggillino, et al.
The Journal of Biological Chemistry|July 4, 2020
Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brainRita Marinelli, Pierangelo Torquato, Desirée Bartolini, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2025
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosisMario Mandalà, Filippo Ugolini, Lorenzo Caldirola, et al.
Biopreservation and Biobanking|May 16, 2023
A New Medium (HistoCold) for Surgical Specimens Preserving to Improve the Preanalytic Issues in Histopathological Samples Handling: Morphologic and Antigenic AnalysisMartina Mandarano, Cristina Pelliccia, Laura Tomasello, et al.
Journal of Medicinal Chemistry|March 12, 2020
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X ReceptorDesirée Bartolini, Francesca De Franco, Pierangelo Torquato, et al.
Pageof 11